BOT 5.22% 35.3¢ botanix pharmaceuticals ltd

Ann: Ethics Approval for Phase 2 Atopic Dermatitis Study Received, page-18

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 183 Posts.
    lightbulb Created with Sketch. 92
    This entity that wants to GTFO must be either more than one or is Matt himself, for looking at the Top 20s there is no one else that could sustain a selling streak over a period of - accordingly https://hotcopper.com.au/threads/an...post=true&direction=previous#.XBmesjF7laQ - more than 7 weeks with 20m shares already sold.
    It'd make sense too considering that he's the only one that may have a clue on the ongoing of the trials...?....unless it's all really about the larger picture of a bearish market that started in October and is getting its toll on most investors reasoning?
    There's no demand cause it is a bear market?
    Last edited by vitruvius: 19/12/18
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
35.3¢
Change
0.018(5.22%)
Mkt cap ! $707.4M
Open High Low Value Volume
33.5¢ 36.0¢ 33.3¢ $2.096M 6.041M

Buyers (Bids)

No. Vol. Price($)
12 138235 35.0¢
 

Sellers (Offers)

Price($) Vol. No.
35.5¢ 20505 4
View Market Depth
Last trade - 14.00pm 26/11/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.